(+33) 06 59 81 50 79 Paris, France

Michele Mondini

After obtaining is PhD in Immunology and Cellular Biology at the University of Turin, Italy, he served for 4 years as CEO and scientific supervisor of the Italian start-up Notopharm, which was focused on the diagnosis and therapy of immune-related disorders. In 2005, he was appointed as contract Professor at the University of Piemonte Orientale, Novara, Italy.

Michele Mondini joined the U1030 research unit at Gustave Roussy in 2011, where he oriented his research activities on the role of the immune system in the response to radiotherapy. He focussed on both the tumour and healthy tissue responses to ionizing radiation. He is specialized in the preclinical development and testing of combinations of radiotherapy with immuno-oncology drugs. He has authored more than 50 articles on radiotherapy, immunotherapy, inflammation and autoimmunity. He is named inventor of five patent applications.

Scroll to Top